Yüklüyor......

Specialty Drug Pricing and Out-of-Pocket Spending on Orally Administered Anticancer Drugs in Medicare Part D, 2010 to 2019

This study describes point-of-sale prices for orally administered anticancer drugs offered through Medicare Part D and out-of-pocket changes in spending as a result of decreasing coinsurance and price changes between 2010 and 2019.

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:JAMA
Asıl Yazarlar: Dusetzina, Stacie B., Huskamp, Haiden A., Keating, Nancy L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Medical Association 2019
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6547115/
https://ncbi.nlm.nih.gov/pubmed/31135837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2019.4492
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!